Osaic Holdings’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153 | Sell |
40
-840
| -95% | -$3.21K | ﹤0.01% | 7021 |
|
|
2025
Q1 | $5.06K | Buy |
880
+300
| +52% | +$1.73K | ﹤0.01% | 6082 |
|
|
2024
Q4 | $2.9K | Sell |
580
-100
| -15% | -$499 | ﹤0.01% | 6333 |
|
|
2024
Q3 | $3.67K | Hold |
680
| – | – | ﹤0.01% | 6217 |
|
|
2024
Q2 | $2.25K | Sell |
680
-6,420
| -90% | -$21.2K | ﹤0.01% | 6392 |
|
|
2024
Q1 | $23.2K | Sell |
7,100
-146
| -2% | -$477 | ﹤0.01% | 5228 |
|
|
2023
Q4 | $25.4K | Sell |
7,246
-39,067
| -84% | -$137K | ﹤0.01% | 5349 |
|
|
2023
Q3 | $309K | Buy |
46,313
+39,166
| +548% | +$262K | ﹤0.01% | 3661 |
|
|
2023
Q2 | $60K | Hold |
7,147
| – | – | ﹤0.01% | 4810 |
|
|
2023
Q1 | $71K | Buy |
7,147
+1
| +0% | +$10 | ﹤0.01% | 4716 |
|
|
2022
Q4 | $50K | Sell |
7,146
-168
| -2% | -$1.18K | ﹤0.01% | 4928 |
|
|
2022
Q3 | $39K | Hold |
7,314
| – | – | ﹤0.01% | 5061 |
|
|
2022
Q2 | $30K | Buy |
7,314
+6,500
| +799% | +$26.7K | ﹤0.01% | 5321 |
|
|
2022
Q1 | $4K | Buy |
814
+3
| +0.4% | +$15 | ﹤0.01% | 6477 |
|
|
2021
Q4 | $4K | Buy |
811
+28
| +4% | +$138 | ﹤0.01% | 6616 |
|
|
2021
Q3 | $6K | Hold |
783
| – | – | ﹤0.01% | 6404 |
|
|
2021
Q2 | $10K | Sell |
783
-217
| -22% | -$2.77K | ﹤0.01% | 6019 |
|
|
2021
Q1 | $12K | Buy |
1,000
+211
| +27% | +$2.53K | ﹤0.01% | 5728 |
|
|
2020
Q4 | $5K | Hold |
789
| – | – | ﹤0.01% | 5697 |
|
|
2020
Q3 | $6K | Buy |
789
+289
| +58% | +$2.2K | ﹤0.01% | 5440 |
|
|
2020
Q2 | $2K | Buy |
+500
| New | +$2K | ﹤0.01% | 5677 |
|